Patents Assigned to KAIROSMED GMBH
  • ORAL MODIFIED RELEASE FORMULATIONS
    Publication number: 20100086599
    Abstract: This invention is directed to an oral modified release formulation of the phytoestrogen 8-Prenylnaringenin in combination with a progestin, preferably with Drospirenone, and several uses thereof. In another aspect of the invention an oral modified formulation of 8-Prenylnaringenin with an immediately releasing progestin, like Drospirenone, is provided as well as several uses thereof.
    Type: Application
    Filed: September 14, 2007
    Publication date: April 8, 2010
    Applicant: KAIROSMED GMBH
    Inventors: Michael Huempel, Wolf Dieter Schleuning, Arno Heuermann, Matthias Krings, Markus Thunecke, Johannes Tack